Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
University of Florence, Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
Bioorg Chem. 2020 Mar;96:103635. doi: 10.1016/j.bioorg.2020.103635. Epub 2020 Jan 29.
Implication of carbonic anhydrases (CAs) in many physiological functions made them attractive therapeutic targets. Herein, we report the synthesis of three series of benzenesulfonamide-based compounds (5a-e, 9a-e and 10a-e) as potential ligands to four of the human CA isoforms (hCA I, hCA II, hCA IX and hCA XII). All synthesized compounds were evaluated for their CA inhibitory activity. Most of the compounds preferentially inhibited the tumor-associated isoforms IX and XII. Series 9a-e and 10a-e showed the highest activity. Of particular interest was compound 10a which demonstrated the highest activity among all compounds with K of 68.3 and 21.5 nM against hCA IX and hCA XII, respectively, in addition to its highest selectivity index. To get deep insight on the interaction of compound 10a with CA, docking experiment was run to study the binding interaction with key amino acids and zinc ion in the catalytic site of the four isoforms studied.
碳酸酐酶(CA)在许多生理功能中的作用使其成为有吸引力的治疗靶点。在此,我们报告了一系列基于苯磺酰胺的化合物(5a-e、9a-e 和 10a-e)的合成,这些化合物可能是针对四种人类 CA 同工酶(hCA I、hCA II、hCA IX 和 hCA XII)的潜在配体。所有合成的化合物都评估了它们对 CA 的抑制活性。大多数化合物优先抑制与肿瘤相关的同工酶 IX 和 XII。9a-e 和 10a-e 系列表现出最高的活性。特别值得注意的是化合物 10a,它对 hCA IX 和 hCA XII 的抑制活性最高,K 值分别为 68.3 和 21.5 nM,此外,它的选择性指数也最高。为了深入了解化合物 10a 与 CA 的相互作用,进行了对接实验,以研究与四个研究的同工酶催化位点中的关键氨基酸和锌离子的结合相互作用。